首页> 外文期刊>The Journal of Emergency Medicine >Effect of the Addition of Vasopressin or Vasopressin Plus Nitroglycerin to Epinephrine on Arterial Blood Pressure during Cardiopulmonary Resuscitation in Humans.
【24h】

Effect of the Addition of Vasopressin or Vasopressin Plus Nitroglycerin to Epinephrine on Arterial Blood Pressure during Cardiopulmonary Resuscitation in Humans.

机译:在人心肺复苏过程中向肾上腺素添加血管加压素或血管加压素加硝酸甘油对动脉血压的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Infusion of a vasopressor during cardiopulmonary resuscitation (CPR) in humans increases end decompression (diastolic) arterial blood pressure, and consequently increases vital organ perfusion pressure and survival. Several vasoactive drugs have been tested alone or in combination, but their hemodynamic effects have not been investigated clinically in humans. Study Objective: We tested the hypothesis that epinephrine (1 mg) co-administered with vasopressin (40 IU) +/- nitroglycerin (300 mug) results in higher diastolic blood pressure than epinephrine alone. Study Design: A prospective, randomized, double-blinded controlled trial in the prehospital setting. The study included 48 patients with witnessed cardiac arrest. Patients received either epinephrine alone (E alone) or epinephrine plus vasopressin (E+V) or epinephrine plus vasopressin plus nitroglycerin (E+V+N). A femoral arterial catheter was inserted for arterial pressure measurement. Outcome Measures: The primary end point was diastolic blood pressure during CPR, 15 min after the first drug administration (T = 15 min). Results: After exclusions, a total of 44 patients were enrolled. Diastolic blood pressures (mm Hg) at T = 15 min were not statistically different between groups (median [interquartile range]: 20 [10], 15 [6], and 15 [13] for E alone, E+V, and E+V+N, respectively. The rate of return of spontaneous circulation was 63% (n = 10) in the epinephrine group, 43% (n = 6) in the epinephrine plus vasopressin group, and 36% (n = 5) in the triple therapy group (NS). Conclusions: Addition of vasopressin or vasopressin plus nitroglycerin to epinephrine did not increase perfusion blood pressure compared to epinephrine alone in humans in cardiac arrest, suggesting the absence of benefit in using these drug combination(s).
机译:背景:在人类心肺复苏(CPR)期间输注血管加压药会增加末端减压(舒张压)动脉血压,从而增加重要器官的灌注压力和生存率。已经对几种血管活性药物进行了单独或组合测试,但尚未在人体中对它们的血液动力学作用进行临床研究。研究目的:我们检验了以下假设:肾上腺素(1 mg)与血管加压素(40 IU)+/-硝酸甘油(300杯)并用会比单独使用肾上腺素导致更高的舒张压。研究设计:院前设置的一项前瞻性,随机,双盲对照试验。该研究纳入了48例心脏骤停的患者。患者接受单独的肾上腺素(单独的E)或肾上腺素加血管加压素(E + V)或肾上腺素加血管加压素加硝酸甘油(E + V + N)。插入股动脉导管以测量动脉压。结果措施:主要终点是在首次给药后15分钟(T = 15分钟)进行CPR期间的舒张压。结果:排除后,共纳入44例患者。 T = 15分钟时各组的舒张压(mm Hg)在两组之间无统计学差异(中位数[四分位间距]:仅E,E + V和E,分别为20 [10],15 [6]和15 [13])肾上腺素组的自发循环恢复率分别为63%(n = 10),肾上腺素加血管加压素组为43%(n = 6),肾上腺素加血管加压素组为36%(n = 5)。结论:与单独使用肾上腺素的人相比,在心脏骤停的人中,在肾上腺素中添加血管加压素或血管加压素加硝酸甘油不会增加灌注血压,这表明使用这些药物组合没有益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号